Using claims data to identify the exact indication of use for biological drugs approved for immune-mediated inflammatory diseases: The VALORE project experience

被引：0
|
作者：
Spini, Andrea [1 ]
Ientile, Valentina [2 ]
Fontana, Andrea [3 ]
Ingrasciotta, Ylenia [4 ]
Tanaglia, Matilde [4 ]
Lopes, Sara [5 ]
Belleudi, Valeria [5 ]
Trifiro, Gianluca [4 ]
机构：
[1] Univ Verona, Verona, Italy
[2] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy
[3] Fdn IRCCS Casa Sollievo della Sofferenza, Unit Biostatist, San Giovanni Rotondo, Italy
[4] Univ Verona, Dept Diagnost & Publ Hlth, Verona, Italy
[5] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
596
引用
收藏
页码：277 / 278
页数：2
相关论文
共 26 条
  • [1] Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project
    Spini, Andrea
    L'Abbate, Luca
    Ingrasciotta, Ylenia
    Pellegrini, Giorgia
    Carollo, Massimo
    Ientile, Valentina
    Leoni, Olivia
    Zanforlini, Martina
    Ancona, Domenica
    Stella, Paolo
    Cavazzana, Anna
    Scapin, Angela
    Lopes, Sara
    Belleudi, Valeria
    Trifiro, Gianluca
    CLINICAL EPIDEMIOLOGY, 2024, 16 : 395 - 407
  • [2] Comments on "Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project" [Letter]
    Rokhmalia, Fitri
    Krihariyani, Dwi
    Luthfiyah, Sari
    Triwiyanto, T.
    CLINICAL EPIDEMIOLOGY, 2024, 16 : 431 - 432
  • [3] Comment on "Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project". [Response to Letter]
    Spini, Andrea
    L'Abbate, Luca
    Ingrasciotta, Ylenia
    Pellegrini, Giorgia
    Carollo, Massimo
    Ientile, Valentina
    Leoni, Olivia
    Zanforlini, Martina
    Ancona, Domenica
    Stella, Paolo
    Cavazzana, Anna
    Scapin, Angela
    Lopes, Sara
    Belleudi, Valeria
    Trifiro, Gianluca
    CLINICAL EPIDEMIOLOGY, 2024, 16 : 445 - 446
  • [4] Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project
    Gianluca Trifirò
    Valentina Isgrò
    Ylenia Ingrasciotta
    Valentina Ientile
    Luca L’Abbate
    Saveria S. Foti
    Valeria Belleudi
    Francesca Poggi
    Andrea Fontana
    Ugo Moretti
    Riccardo Lora
    Alberto Sabaini
    Ilenia Senesi
    Carla Sorrentino
    Maria R. Puzo
    Angela Padula
    Mariano Fusco
    Roberta Giordana
    Valentina Solfrini
    Aurora Puccini
    Paola Rossi
    Stefania Del Zotto
    Olivia Leoni
    Martina Zanforlini
    Domenica Ancona
    Vito Bavaro
    Donatella Garau
    Stefano Ledda
    Salvatore Scondotto
    Alessandra Allotta
    Marco Tuccori
    Rosa Gini
    Giampaolo Bucaneve
    David Franchini
    Anna Cavazzana
    Valeria Biasi
    Stefania Spila Alegiani
    Marco Massari
    BioDrugs, 2021, 35 : 749 - 764
  • [5] Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project
    Trifiro, Gianluca
    Isgro, Valentina
    Ingrasciotta, Ylenia
    Ientile, Valentina
    L'Abbate, Luca
    Foti, Saveria S.
    Belleudi, Valeria
    Poggi, Francesca
    Fontana, Andrea
    Moretti, Ugo
    Lora, Riccardo
    Sabaini, Alberto
    Senesi, Ilenia
    Sorrentino, Carla
    Puzo, Maria R.
    Padula, Angela
    Fusco, Mariano
    Giordana, Roberta
    Solfrini, Valentina
    Puccini, Aurora
    Rossi, Paola
    Del Zotto, Stefania
    Leoni, Olivia
    Zanforlini, Martina
    Ancona, Domenica
    Bavaro, Vito
    Garau, Donatella
    Ledda, Stefano
    Scondotto, Salvatore
    Allotta, Alessandra
    Tuccori, Marco
    Gini, Rosa
    Bucaneve, Giampaolo
    Franchini, David
    Cavazzana, Anna
    Biasi, Valeria
    Alegiani, Stefania Spila
    Massari, Marco
    BIODRUGS, 2021, 35 (06) : 749 - 764
  • [6] How much Frequently are Biological Drugs Used in Patients Over 65 Years With Immune-Mediated Inflammatory Diseases Through The Italian VALORE Distributed Database Network
    Soardo, Federica
    Costa, Giorgio
    Spini, Andrea
    Bellitto, Chiara
    L'Abbate, Luca
    Mathieu, Clement
    Ingrasciotta, Ylenia
    Carollo, Massimo
    Leoni, Olivia
    Mazzone, Arianna
    Ancona, Domenica
    Stella, Paolo
    Cavazzana, Anna
    Scapin, Angela
    Lopes, Sara
    Belleudi, Valeria
    Ledda, Stefano
    Carta, Paolo
    Rossi, Paola
    Ejlli, Lucian
    Sapigni, Ester
    Puccini, Aurora
    Scarpelli, Rita Francesca
    De Sarro, Giovambattista
    Allotta, Alessandra
    Pollina, Sebastiano Addario
    Da Cas, Roberto
    Bucaneve, Giampaolo
    Mangano, Antea Maria Pia
    Balducci, Francesco
    Sorrentino, Carla
    Senesi, Ilenia
    Tuccori, Marco
    Gini, Rosa
    Alegiani, Stefania Spila
    Massari, Marco
    Urru, Silvana Anna Maria
    Campomori, Annalisa
    Trifiro, Gianluca
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 392 - 393
  • [7] PATIENT PREFERENCES IN CHRONIC IMMUNE-MEDIATED INFLAMMATORY DISEASES POTENTIALLY TREATED WITH BIOLOGICAL DRUGS: REAL-WORLD DATA ANALYSIS
    Tornero-Molina, J.
    Ginard-Vicens, D.
    Guigini, M. A.
    Burniol-Garcia, A.
    Crespo, C.
    VALUE IN HEALTH, 2022, 25 (12) : S449 - S449
  • [8] Safety Assessment of Biologics for Immune-Mediated Inflammatory Diseases Using Italian VALORE Healthcare Database Network and National Spontaneous Reporting System
    Benoni, R.
    Ingrasciotta, Y.
    Ferrajolo, C.
    Ientile, V.
    Fiore, E. S.
    Arzenton, E.
    Cavazzana, A.
    Biasi, V.
    Rossi, P.
    Ejlli, L.
    Belleudi, V.
    Poggi, F. R.
    Solfrini, V.
    Puccini, A.
    Trifiro, G.
    DRUG SAFETY, 2022, 45 (10) : 1147 - 1148
  • [9] SEX DIFFERENCES IN ADVERSE DRUG REACTIONS FROM BIOLOGICAL USE IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES
    Gosselt, H.
    Van Lint, J.
    Tas, S.
    Van den Bemt, B.
    Vonkeman, H.
    Hoentjen, F.
    Nurmohamed, M.
    Van Doorn, M.
    Jessurun, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 595 - 596
  • [10] Patient preferences in chronic immune-mediated inflammatory diseases potentially treated with biological drugs: discrete choice analysis using real-world data analysis
    Ginard-Vicens, Daniel
    Tornero-Molina, Jesus
    Fernandez-Fuente-Burson, L.
    Gomez, M. L. Gonzalez
    Moreno, E.
    Salleras, M.
    Guigini, M. A.
    Burniol-Garcia, A.
    Crespo, C.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (08) : 959 - 965
123